Long-term oncologic outcomes in pathologic tumor response after neoadjuvant chemoradiation for locally advanced rectal cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jeong-Soo Park | - |
dc.contributor.author | 백정흠 | - |
dc.contributor.author | Won-Suk Lee | - |
dc.contributor.author | Jun-Young Yang | - |
dc.contributor.author | Woon-Kee Lee | - |
dc.contributor.author | Kun Kuk Kim | - |
dc.contributor.author | Yeon-Ho Park | - |
dc.date.available | 2020-02-27T14:43:25Z | - |
dc.date.created | 2020-02-12 | - |
dc.date.issued | 2018-06 | - |
dc.identifier.issn | 1738-8082 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/4982 | - |
dc.description.abstract | Purpose: The status of tumor regression in rectal cancer after neoadjuvant concurrent chemoradiotherapy (CCRT) has significant effect on tumor recurrence and patient survival. The aim of this study was to evaluate the long-term oncologic outcomes of rectal cancer patients presenting complete response or down-staging of rectal cancer compared to patients with non-response after neoadjuvant therapy in advanced mid-to-lower rectal cancer. Methods: We retrospectively reviewed 79 patients with stage II/III mid-to-lower rectal cancer following neoadjuvant CCRT between March 2003 and April 2012. Patients were classified into three groups according to down-staging tumor response after neoadjuvant CCRT: complete response group (CRG), partial response group (PRG), and non-response group (NRG). Results: Of the 79 patients in the study, eight (10.1%), 31 (39.2%), and 40 (50.7%) were classified as CRG, PRG, and NRG, respectively. Median follow-up period was 57 months. There was significant difference in local recurrence (P=0.012) between the three groups, yet there was no significant difference in overall survival (CRG, 100%; PRG, 82.5%; NRG, 74.0%; P=0.244). There was a significant difference in disease- free survival (CRG, 100%; PRG, 90.1%; NRG, 57.7%; P=0.006). Conclusion: Tumor response with complete response or down-staging provided better oncologic outcomes in terms of disease-free survival and local recurrence in locally advanced rectal cancer patients. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | 대한종양외과학회 | - |
dc.relation.isPartOf | 대한종양외과학회지 | - |
dc.title | Long-term oncologic outcomes in pathologic tumor response after neoadjuvant chemoradiation for locally advanced rectal cancer | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 2 | - |
dc.identifier.doi | 10.14216/kjco.18006 | - |
dc.identifier.bibliographicCitation | 대한종양외과학회지, v.14, no.1, pp.37 - 42 | - |
dc.identifier.kciid | ART002368016 | - |
dc.description.isOpenAccess | N | - |
dc.citation.endPage | 42 | - |
dc.citation.startPage | 37 | - |
dc.citation.title | 대한종양외과학회지 | - |
dc.citation.volume | 14 | - |
dc.citation.number | 1 | - |
dc.contributor.affiliatedAuthor | Jeong-Soo Park | - |
dc.contributor.affiliatedAuthor | 백정흠 | - |
dc.contributor.affiliatedAuthor | Won-Suk Lee | - |
dc.contributor.affiliatedAuthor | Jun-Young Yang | - |
dc.contributor.affiliatedAuthor | Woon-Kee Lee | - |
dc.contributor.affiliatedAuthor | Kun Kuk Kim | - |
dc.contributor.affiliatedAuthor | Yeon-Ho Park | - |
dc.subject.keywordAuthor | Rectal neoplasms | - |
dc.subject.keywordAuthor | Chemoradiotherapy | - |
dc.subject.keywordAuthor | Surgical oncology | - |
dc.description.journalRegisteredClass | kci | - |
dc.description.journalRegisteredClass | other | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.